Cite
HARVARD Citation
Jain, P. et al. (2017). Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients. Cancer. 123 (22), pp. 4391-4402. [Online].